Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Cancer Immunology Research|January 12, 2026
Cytometric Atlas of Combination Immunotherapy in Pancreatic Cancer: Blood-Based Signatures Reveal Vaccine and Checkpoint Inhibitor ResponsesDimitri N Sidiropoulos, Zhehao Zhang, Jennifer N Durham, et al.
Nature Communications|November 12, 2024
Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trialMarina Baretti, Ludmila Danilova, Jennifer N Durham, et al.
Cancer Immunology Research|January 23, 2024
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD-1 TherapyJiang Chen, Zohreh Amoozgar, Xin Liu, et al.
The Journal of Investigative Dermatology|January 21, 2024
Single-Cell RNA Sequencing Reveals Dysregulated POSTN+WNT5A+ Fibroblast Subclusters in Prurigo NodularisJay R Patel, Marina Z Joel, Kevin K Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2023
Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid TumorsKaysia Ludford, Won Jin Ho, Jane V Thomas, et al.
Nature Communications|February 24, 2026
iCLAP: an innovative method for integrable co-detection of low-abundance antigens with high-plex immunostainingFan Wu, Shuyuan Zheng, Yani Chen, et al.
JCI Insight|August 6, 2024
Phosphodiesterase-5 inhibition collaborates with vaccine-based immunotherapy to reprogram myeloid cells in pancreatic ductal adenocarcinomaNicole E Gross, Zhehao Zhang, Jacob T Mitchell, et al.
Oncoimmunology|August 15, 2025
A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophagesKatherine M Bever, Sarah M Shin, Jennifer N Durham, et al.
Journal of Hepatology|November 8, 2025
DNAJ-PKAc induces metabolic rewiring and enhanced glutamine flux in fibrolamellar HCCZeal Kamdar, Ethan Neumann, Kathryn Howe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2025
Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancerEric S Christenson, Won Jin Ho, Daniel Shu, et al.
Pageof 11